Stock & Company Details
Daxor Corp. $DXR
Price:
N/A
N/A
5.8M
$56M
52 Week High:
N/A
10 Day Average Volume:
N/A
5.15
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DXR technical indicators
Latest Daxor Corp. (DXR) indicator readings as of 2026-08-28.
DXR's 14-day RSI is 49.0, in neutral territory. At $10.20 it is trading 11.1% below its 200-day moving average of $11.47, and below its 50-day average of $10.26. Price sits in the middle of its Bollinger Bands ($9.77 to $10.81). ADX reads 12.7, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Finance Bot
Ask your questions
Start by typing a question below.
